NIH-funded research NIH-funded research

How a natural protein (MFG-E8) may help the liver heal after cell loss

Official title: Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response

Funded at Jesse Brown VA Medical Center · NIH-11213919 · Data updated 2026-11-12

This work looks at whether the protein MFG-E8 helps the liver recover after liver-cell death, which could help people with acute or chronic liver injury.

More Wound research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJesse Brown VA Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 30, 2023
Project endSeptember 30, 2027
Funding year2026
NIH project number5I01BX006085-03
Project IDNIH-11213919 on NIH RePORTER

Who could benefit from this research

Could help

People with recent liver injury or chronic liver disease—such as drug-induced injury, ischemia/reperfusion damage, nonalcoholic fatty liver disease, or alcohol-related liver disease—are the kinds of patients who might ultimately benefit.

Less likely to help

Patients with inherited metabolic liver disorders unrelated to hepatocyte apoptosis, those needing immediate liver transplantation, or people whose conditions are driven by unrelated mechanisms are unlikely to benefit directly from this work.

What this research studies

From your perspective, researchers are using a new mouse model that mimics targeted liver-cell death to understand how the liver heals. They will trigger controlled hepatocyte apoptosis in transgenic mice and track inflammation, tissue repair, and scarring over time. The team will measure levels and activity of the protein MFG-E8 and perform molecular analyses of liver tissue to see if MFG-E8 speeds recovery. Results could point to ways to protect the liver and encourage regeneration after injury.

Why it matters

Potential benefit: If successful, this work could reveal new strategies to help the liver recover after injury and reduce progression to cirrhosis or liver failure.

How similar studies have gone: Some preclinical studies in other tissues suggest MFG-E8 can aid repair, but applying it to apoptosis-driven liver healing is largely new and not yet proven.

Where this research is happening

  • Jesse Brown VA Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Tan, Xiao-Di — Jesse Brown VA Medical Center
  • Study coordinator: Tan, Xiao-Di

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.